Summary: Accumen was acquired by hc1 to combine their expertise in healthcare data and consulting, accelerating the use of lab data insights to improve patient care, streamline operations, and enhance financial performance for health systems.
Takeaways:
- The acquisition of Accumen aims to transform underused lab data into valuable insights that improve patient care and generate financial growth for health systems.
- The integration of hc1’s Lab Insights Platform with Accumen’s lab expertise enables health systems to optimize lab performance without straining IT resources or disrupting operations.
- This acquisition positions hc1 as a leading provider of lab data solutions, driving faster results in lab stewardship, supply chain management, and staffing for health systems.
Hc1, a healthcare information technology leader focused on improving patient care and reducing costs through real-time lab data insights, has acquired Accumen, a healthcare performance consulting company based in Scottsdale, Arizona.
Together, hc1 and Accumen will accelerate healthcare progress by harnessing the power of lab data to generate insights that improve patient care, streamline operations, and reduce costs, all while achieving healthy growth to enhance financial performance, the companies say.
“The merger between hc1 and Accumen jumpstarts progress for the healthcare industry by taking labs off the backburner and turning them into goldmines of data and financial growth for health systems,” says Bradley A. Bostic, CEO of hc1. “All health systems have a lab, and yet they are underused as a tool to improve patient health through data-driven insights. By integrating hc1’s advanced data management technology and AI-powered analytics—the hc1Lab Insights Platform—with Accumen’s lab expertise, we are addressing the massive demand from health systems to mine maximum value from lab data. After over a decade of perfecting our approach and technology, we are partnering with healthcare leaders who want to unlock the hidden value of lab data within their health systems. Ultimately, it’s about effectively diagnosing patients and generating healthy financial results. hc1 is expanding faster than ever because we deliver both benefits at scale with a turnkey, secure cloud solution. This is truly the force-multiplier health systems have been looking for.”
With the acquisition of Accumen, hc1 delivers results faster and sustains improvements across the supply chain, blood management, staffing, lab stewardship, outreach growth, and beyond—all while effectively avoiding resource constraints. Expert consultants make it easy for health systems to go live through a proven process that doesn’t strain IT resources or disrupt ongoing operations, according to the companies.
Terms of the acquisition were not disclosed. The acquisition positions hc1 as a comprehensive solutions provider for transforming diagnostic labs into strategic assets for health systems.
Further reading: Michigan Medicine Signs Agreement with hc1 Insights For Performance Analytics
